Editas Medicine, Inc.

EDIT

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001650664

SEC filings (opens in a new tab)

In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Editas Medicine, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of EDIT: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	194	5	197	+8
Shares	43.0M	300.7K	49.9M	+7.21M (+16.9%)
Value	$149.3M	$1.04M	$102.5M	−$45.8M (−30.9%)

5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Editas Medicine, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to EDIT in Q4 2025
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	733,483	$1.50M	0.00%
Gsa Capital Partners LLP	568,809	$1.17M	0.10%
Eversept Partners, LP	290,919	$596.4K	0.03%
Quadrature Capital Ltd	107,376	$220.1K	0.00%
EntryPoint Capital, LLC	84,554	$173.3K	0.07%
Joel Isaacson & Co., LLC	68,144	$139.7K	0.00%
Two Sigma Securities, LLC	43,870	$89.9K	0.01%
Virtu Financial LLC	43,228	$89.0K	0.00%
StoneX Group Inc.	15,855	$32.5K	0.00%
Callan Family Office, LLC	15,832	$32.5K	0.00%
Independent Financial Group, LLC	15,410	$31.6K	0.00%
Keystone Financial Group	14,050	$28.8K	0.00%
Franklin Resources Inc	10,702	$21.9K	0.00%
Dunhill Financial, LLC	4,000	$8.20K	0.00%
Ronald Blue Trust, Inc.	1,600	$3.28K	0.00%
Quattro Advisors LLC	1,578	$3.23K	0.00%
Federated Hermes, Inc.	747	$1.53K	0.00%
GAMMA Investing LLC	548	$1.12K	0.00%
Massmutual Trust Co FSB	530	$1.09K	0.00%
Pinnacle Wealth Planning Services, Inc.	100	$205	0.00%
Smartleaf Asset Management LLC	100	$204	0.00%
SHP Wealth Management	90	$184	0.00%
Curio Wealth, LLC	77	$170	0.00%
Evolution Wealth Management Inc.	50	$103	0.00%
Hilton Head Capital Partners, LLC	27	$55	0.00%
Essential Investment Partners LLC	20	$41	0.00%
SageView Advisory Group, LLC	14	$29	0.00%
Quintet Private Bank (Europe) S.A.	6	$12	0.00%
Hantz Financial Services, Inc.	100	$0	0.00%

Sold out (21)

Institutions that held Editas Medicine, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of EDIT in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Wellington Management Group LLP	295,257	$1.02M
Deutsche Bank AG	79,286	$275.1K
Headlands Technologies LLC	76,575	$265.7K
Dynamic Technology Lab Private Ltd	72,840	$253.0K
Bailard, Inc.	33,875	$117.5K
Susquehanna Fundamental Investments, LLC	27,642	$95.9K
Cerity Partners LLC	14,339	$49.8K
Prudential Financial Inc	11,457	$39.8K
Buckingham Strategic Partners	11,164	$36.3K
Baader Bank INC	14,545	$31.2K
Koss-Olinger Consulting, LLC	10,000	$22.0K
Principal Securities, Inc.	575	$2.00K
Zurcher Kantonalbank (Zurich Cantonalbank)	360	$1.25K
Newbridge Financial Services Group, Inc.	300	$1.04K
Ameriflex Group, Inc.	300	$1.04K
Westside Investment Management, Inc.	200	$695
Root Financial Partners, LLC	100	$347
Advisory Services Network, LLC	99	$344
Morton Brown Family Wealth, LLC	65	$226
AdvisorNet Financial, Inc	25	$87
Harbour Investments, Inc.	19	$66

Not filed for Q4 2025 yet (5)

Institutions that held Editas Medicine, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EDIT in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Cubist Systematic Strategies, LLC	286,482	$994.1K
Point72 (DIFC) Ltd	9,878	$34.3K
Point72 Europe (London) LLP	3,833	$13.3K
AllSquare Wealth Management LLC	475	$1.65K
Abich Financial Wealth Management LLC	12	$42